Nanjing Legend Biotechnology describes new simian ICP47-based therapeutic cells Dec. 14, 2021 No Comments
Shanghai Longwood Biopharmaceuticals synthesizes PD-1/PD-L1 interaction inhibitors Dec. 14, 2021 No Comments
Biosion licenses BSI-04702 to OBI Pharma to develop next-generation biologics Dec. 13, 2021 No Comments
Loss of SETDB1-TRIM28 complex boosts the antitumor effects of immune checkpoint blockade Dec. 9, 2021 No Comments
Attenuated T. gondii injection synergizes with PD-L1 checkpoint blockade against mouse tumors Dec. 9, 2021 No Comments
Proteogenomics approach identifies neoantigens for T-cell immunotherapy in pediatric brain tumors Dec. 9, 2021 No Comments
RSS